# Pregabalin for the Treatment of Uremic Pruritus

> **NCT01852318** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 210 (estimated)

## Conditions studied

- Uremic Pruritus

## Interventions

- **DRUG:** pregabalin 75mg daily for 12 weeks
- **DRUG:** fexofenadine 60 mg daily for 12 weeks
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01852318
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2014-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852318, "Pregabalin for the Treatment of Uremic Pruritus". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01852318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*